Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | SRC | P12931 | 1/20 | 0.31 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16334142 | 0.84 | MEN1 (0.33) | MEN1ALDH1A1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL20553777 | 0.77 | MEN1 (0.38) | MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL715825 | 0.73 | ALDH1A1 (0.33) | MEN1ALDH1A1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL6382158 | 0.73 | ALDH1A1 (0.40) | MEN1ALDH1A1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL20553962 | 0.72 | TRPA1 (0.47) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL27862651 | 0.72 | ALDH1A1 (0.33) | MEN1ALDH1A1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL30122516 | 0.72 | ALDH1A1 (0.39) | MEN1ALDH1A1MAPTKMT2ASMN1; SMN2 | |
| SCHEMBL339008 | 0.71 | TP53 (0.43) | ALDH1A1MAPT | |
| SCHEMBL2961402 | 0.71 | CYP1A2 (0.41) | ALDH1A1SMN1; SMN2 | |
| SCHEMBL1044722 | 0.71 | MEN1 (0.47) | MEN1ALDH1A1MAPTKMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3925989-A1 | MOLECULAR WEIGHT CONTROL OF POLYOLEFINS USING HALOGENATED BIS-PHENYLPHENOXY CATALYSTS | Dow Global Technologies LLC (US) | 2021-12-22 | — | — | EP | claimed |
| EP-3578578-A1 | BIS-BIPHENYLPHENOXY CATALYSTS FOR POLYMERIZATION OF LOW MOLECULAR WEIGHT ETHYLENE-BASED POLYMERS | Dow Global Technologies Llc (US) | 2019-12-11 | — | — | EP | claimed |
| US-10144791-B2 | Molecular weight control of polyolefins using halogenated bis-phenylphenoxy catalysts | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-12-04 | — | — | US | claimed |
| US-9975975-B2 | Bis-biphenylphenoxy catalysts for polymerization of low molecular weight ethylene-based polymers | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-05-22 | — | — | US | claimed |
| US-20170158790-A1 | MOLECULAR WEIGHT CONTROL OF POLYOLEFINS USING HALOGENATED BIS-PHENYLPHENOXY CATALYSTS | DOW GLOBAL TECHNOLOGIES LLC | 2017-06-08 | — | — | US | claimed |
| EP-3172250-A1 | BIS-BIPHENYLPHENOXY CATALYSTS FOR POLYMERIZATION OF LOW MOLECULAR WEIGHT ETHYLENE-BASED POLYMERS | Dow Global Technologies Llc (US) | 2017-05-31 | — | — | EP | claimed |
| US-20170137550-A1 | BIS-BIPHENYLPHENOXY CATALYSTS FOR POLYMERIZATION OF LOW MOLECULAR WEIGHT ETHYLENE-BASED POLYMERS | DOW GLOBAL TECHNOLOGIES LLC | 2017-05-18 | — | — | US | claimed |
| EP-3013871-A1 | MOLECULAR WEIGHT CONTROL OF POLYOLEFINS USING HALOGENATED BIS-PHENYLPHENOXY CATALYSTS | Dow Global Technologies LLC (US) | 2016-05-04 | — | — | EP | claimed |
| US-20160108156-A1 | MOLECULAR WEIGHT CONTROL OF POLYOLEFINS USING HALOGENATED BIS-PHENYLPHENOXY CATALYSTS | DOW GLOBAL TECHNOLOGIES LLC | 2016-04-21 | — | — | US | claimed |
| WO-2016014749-A1 | BIS-BIPHENYLPHENOXY CATALYSTS FOR POLYMERIZATION OF LOW MOLECULAR WEIGHT ETHYLENE-BASED POLYMERS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-01-28 | — | — | WO | claimed |
| WO-2014210333-A1 | MOLECULAR WEIGHT CONTROL OF POLYOLEFINS USING HALOGENATED BIS-PHENYLPHENOXY CATALYSTS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2014-12-31 | — | — | WO | claimed |
| WO-2011146044-A1 | PROCESS FOR SELECTIVELY POLYMERIZING ETHYLENE AND CATALYST THEREFOR | DOW GLOBAL TECHNOLOGIES LLC (US) | 2011-11-24 | — | — | WO | claimed |
| CN-115298227-B | Group III and lanthanide bis-phenyl-phenoxy metal-ligand complexes | 陶氏环球技术有限责任公司 | 2024-06-04 | — | — | CN | disclosed |
| WO-2024050359-A1 | GROUP III-HALIDE OR LANTHANIDE-HALIDE BIS(PHENYLPHENOXY) METAL−LIGAND COMPLEXES | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-03-07 | — | — | WO | disclosed |
| WO-2024050368-A1 | METHOD OF PRODUCING MULTIMODAL POLYETHYLENE USING AT LEAST ONE GROUP III-BASED OR LANTHANIDE-BASED BIPHENYLPHENOXY CATALYST | DOW GLOBAL TECHNOLOGIES LLC (US) | 2024-03-07 | — | — | WO | disclosed |
| EP-4332133-A2 | GROUP III AND LANTHANIDE BIS-PHENYL-PHENOXY METAL-LIGAND COMPLEXES | Dow Global Technologies LLC (US) | 2024-03-06 | — | — | EP | disclosed |
| WO-2013101376-A1 | HYPERBRANCHED OLEFIN OIL-BASED DIELECTRIC FLUID | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-07-04 | — | — | WO | disclosed |
| WO-2013101375-A1 | PROCESS FOR PRODUCING LOW MOLECULAR WEIGHT ETHYLENE- AND ALPHA-OLEFIN-BASED MATERIALS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2013-07-04 | — | — | WO | disclosed |
| WO-2011146044-A1 | PROCESS FOR SELECTIVELY POLYMERIZING ETHYLENE AND CATALYST THEREFOR | DOW GLOBAL TECHNOLOGIES LLC (US) | 2011-11-24 | — | — | WO | disclosed |
| US-20110282018-A1 | PROCESS FOR SELECTIVELY POLYMERIZING ETHYLENE AND CATALYST THEREFOR | DOW GLOBAL TECHNOLOGIES LLC | 2011-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110282018-A1 | PROCESS FOR SELECTIVELY POLYMERIZING ETHYLENE AND CATALYST THEREFOR | WEE2, NOTUM, WEE1 | MEN1 1052/4885ALDH1A1 2392/4885MAPT 1699/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.